FORWARD FEATURES CALENDAR

Deals & Transactions

FFL Partners invests in US Orthopedic Partners

FFL Partners (FFL), a private equity firm focused on growth investments in middle market companies, has formed a new orthopaedic health services organisation, US Orthopedic Partners (USOP). The Thurston Group, a Chicago-based private equity firm with a focus on investing in healthcare companies, also invested in USOP. Financial terms of the

Sun Capital Partners affiliate invests in Mancini’s Sleepworld

An affiliate of private investment firm Sun Capital Partners (Sun Capital), has made an investment in Mancini’s Sleepworld (Mancini’s” or “the Company”), a mattress retailer serving the Northern California market. Terms of the private transaction have not been disclosed.  Founded by the Mancini family in 1969, Mancini’s Sleepworld sells leading brand

Cornerstone completes acquisition of FXPress Payment Services

Cornerstone Brands has completed its acquisition of FXPress Payment Services Ltd (FXPress) following consent from the FCA. FXPress, a regulated Authorised Payment Institution providing cross-border payment services, is now a wholly-owned subsidiary of Cornerstone.   Cornerstone is also pleased to announce that it has received the consent of the FCA for

Peak Rock Capital affiliate completes acquisition of Halo Foods

An affiliate of middle-market private investment firm Peak Rock Capital (Peak Rock), a middle-market private investment firm, has completed its acquisition of Halo Foods Ltd (Halo) in partnership with the exisiting management team.Headquartered in Newport, Wales (UK), Halo is a leading manufacturer of healthy bars and snacks, with an extensive

GCV secures GBP1m in growth capital

Fintech company, Growth Capital Ventures (GCV), has secured GBP1 million of growth capital from institutional investors to continue its expansion and fast-track the growth of Britain’s burgeoning tech sector. GCV has now opened up the investment round to new private investors via its online investment platform – growthfunders.com Investment from the

Stemson Therapeutics Secures GBP6m in seed financing

Stemson Therapeutics announced today £6 million seed financing from impact investor Fortunis Capital and Allergan Aesthetics, an AbbVie Company, to advance development of Stemson’s therapeutic solution to cure hair loss. Stemson aims to restore human hair growth with a novel approach using the patient’s own cells to generate new hair follicles.

Events

12 November, 2026 – 5:00 pm

Directory Listings